Closed · HR001121S0037 · CFDA 12.910 · Discretionary

Assessing Immune Memory (AIM)

Federal grant opportunity posted by DARPA - Biological Technologies Office, cataloged on Grants.gov.

Varies
Award range
Closed
Status
October 26, 2021
Close date
-
Expected awards

The verdict

Assessing Immune Memory (AIM) is a closed discretionary listing from DARPA - Biological Technologies Office that offered Varies by applicant. Future funding cycles may be published under the same CFDA number.

Varies
award range
Closed
application status
12.910
CFDA program

Opportunity snapshot. This Grants.gov announcement - Assessing Immune Memory (AIM) - is cataloged under number HR001121S0037 and tied to CFDA assistance listing 12.910, posted by DARPA - Biological Technologies Office. Grants.gov currently shows the opportunity as closed, first posted on August 20, 2021 and last updated on September 7, 2021. The funding category is Discretionary, delivered as a procurement contract.

Award economics. The award range on file is Varies by applicant. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. This opportunity closed on October 26, 2021. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.

Award Range

Varies by applicant

Close Date

October 26, 2021

See Full Announcement for details.

Posted

August 20, 2021

Instrument

Procurement Contract

Description

Military service members rely on effective vaccination for the prevention of communicable disease as well as to guard against biothreat exposure. Many current vaccines lack durability (i.e., do not provide effective protection over long periods of time), and there are multiple pathogens and threats that lack prophylactic options altogether. It is currently impossible to predict vaccine durability from early response profiles, largely owing to ignorance of mechanisms underlying immune memory as well as an inability to measure the cellular contributors that invoke long-lasting immune protection. Formation of immune memory is a complex physiological process characterized by a diverse array of cellular interactions and signaling processes. AIM seeks to develop a platform capability to predict immune memory informed by a systems-level view of the host response to vaccination and its mechanisms.

Eligibility

Grants.gov lists this opportunity under eligibility category code 25. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

BAA Coordinator AIM@darpa.mil

Key Dates

Posted August 20, 2021
Close Date October 26, 2021
Archive Date November 25, 2021
Last Updated September 7, 2021

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "Assessing Immune Memory (AIM)", offered by DARPA - Biological Technologies Office. It is associated with CFDA program 12.910. Military service members rely on effective vaccination for the prevention of communicable disease as well as to guard against biothreat exposure. Many current vaccines lack durability (i.e., do not pr...
Is this opportunity still open?
No, this opportunity is closed. It closed on October 26, 2021. Check the parent program page for future funding cycles.
How much funding is available?
The award range for this opportunity is Varies by applicant.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

More from DARPA - Biological Technologies Office

Open Closes September 30, 2026

Biological Technologies

View →

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants